Mancini Anthony bought RVMD
March 25, 2026 · Form 4 insider transaction
Mancini Anthony bought 37,450 shares of Revolution Medicines, Inc. at $33.62 per share, a transaction worth $1.26M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
37,450
Price
$33.62
Total value
$1.26M
InsiderMancini Anthony
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 25, 2026
Filing dateMarch 26, 2026
Shares owned after91,850
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025.; Includes 54,400 Restricted Stock Units.